FOR IMMEDIATE RELEASE
January 29, 2026
(Colorado Springs, CO) – The S3 Collective, a national nonprofit organization advancing the cannabis industry through collaboration, education, and standardization, announced today that its board member and co-founder, David Vaillencourt, has been elected Chair of ASTM International’s Committee D37 on Cannabis, and Darwin Millard — technical director of Cannabis Safety & Quality (CSQ) — has been elected Vice Chair for the 2026–2027 term. Vaillencourt, a long-time standards advocate and founder and CEO of The GMP
Collective, has served on Committee D37 since its inception and was most recently its Vice Chair. In his new role, he aims to ensure that standards remain relevant, inclusive, and broadly adopted by regulators and industry—driving safe, consistent products and real-world public health impact.
Millard, known as the “Spock of Cannabis,” brings deep technical experience to the Vice Chair role. At CSQ, a standard and certification program developer and one of S3
Collective’s founding members, he has focused on strengthening safety and quality across the supply chain through accredited certification. He is committed to delivering cannabis/hemp standards that are practical, implementable, and valuable across global markets.
The D37 officer ballot closed on December 20, 2025, following a highly competitive election with exceptional candidates across every position. Terry Grajczyk was elected Membership Secretary. The Chair race was decided by a narrow margin, and a tie in the Recording Secretary vote has triggered a runoff, with voting open to D37 members through January 6 at 11:59pm ET for ASTM members.
Together, Vaillencourt and Millard have articulated a shared vision for D37: strengthening trust in the marketplace through standards that are credible and widely implemented. They emphasize that consensus standards hold value only when meaningfully used by regulators, businesses, and consumers — promoting clearer expectations, improved safety, and greater efficiency across the global cannabis and hemp industries. Both are committed to expanding member participation, elevating diverse scientific and regulatory expertise, and advancing standards aligned with real-world needs.
S3 Collective encourages cannabis stakeholders — including operators, regulators, public health experts, medical practitioners, and patient advocates — to participate in ASTM D37’s consensus process to help shape standards that protect workers, patients, and consumers. For guidance on engagement, membership, or standards collaboration, contact S3 Collective.
About S3 Collective
The S3 Collective is a 501(c)(3) nonprofit organization committed to advancing the cannabis, hemp, and botanical industries through collaboration, education, and standardization. By assisting in the development of robust standards, fostering open communication channels, and providing scientifically validated resources, S3 Collective empowers stakeholders to make informed decisions that promote public health and safety. S3 Collective is the sole non profit to be selected as part of the FDA’s Network of Experts for Cannabinoid safety.
About Cannabis Safety & Quality (CSQ)
CSQ is a safety-driven company setting reliable standards for the cannabis industries (marijuana and hemp) to help companies minimize risk, protect their brand, and provide the best product for their consumers. CSQ is the first accredited, cGMP-conformant, safety and quality management certification program for cannabinoid products. The CSQ certification program was developed by and for the cannabis industry to meet ASTM/ISO standards and market-by-market regulatory requirements from seed to sale. For more information about CSQ’s standards, visit www.csqcertification.com.
Media Contact
S3 Collective
